Cognition Therapeutics, Inc. (CGTX)
0.9796
-0.01
(-1.05%)
USD |
NASDAQ |
Sep 10, 16:00
0.95
-0.03
(-3.02%)
After-Hours: 20:00
Cognition Therapeutics Shareholders Equity (Quarterly) : 33.02M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.02M |
| March 31, 2026 | 29.91M |
| December 31, 2025 | 34.27M |
| September 30, 2025 | 36.53M |
| June 30, 2025 | 7.029M |
| March 31, 2025 | 12.27M |
| December 31, 2024 | 18.75M |
| September 30, 2024 | 14.48M |
| June 30, 2024 | 23.01M |
| March 31, 2024 | 28.86M |
| December 31, 2023 | 24.47M |
| Date | Value |
|---|---|
| September 30, 2023 | 28.93M |
| June 30, 2023 | 34.39M |
| March 31, 2023 | 35.78M |
| December 31, 2022 | 40.25M |
| September 30, 2022 | 39.32M |
| June 30, 2022 | 43.90M |
| March 31, 2022 | 48.74M |
| December 31, 2021 | 51.27M |
| September 30, 2021 | -86.72M |
| June 30, 2021 | -83.68M |
| March 31, 2021 | -67.85M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 217.65M |
| Bristol Myers Squibb Co. | 22.32B |
| Structure Therapeutics, Inc. | 1.354B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 38.90M |
| Total Liabilities (Quarterly) | 5.872M |
| Debt to Equity Ratio | 0.0178 |
| Current Ratio | 7.027 |
| Net Debt Paydown Yield | -0.02% |